APA (7th ed.) Citation

Rasooli, R., Mandegary, A., & Aghebat-Bekheir, S. (2026). Pirfenidone–Silymarin Combination Mitigates Paraquat-Induced Lung Fibrosis via Oxidative and Pro-Fibrotic Pathway Modulation. Natural Product Communications, 21(2), 1. https://doi.org/10.1177/1934578X251405972

Chicago Style (17th ed.) Citation

Rasooli, Rokhsana, Ali Mandegary, and Saeed Aghebat-Bekheir. "Pirfenidone–Silymarin Combination Mitigates Paraquat-Induced Lung Fibrosis via Oxidative and Pro-Fibrotic Pathway Modulation." Natural Product Communications 21, no. 2 (2026): 1. https://doi.org/10.1177/1934578X251405972.

MLA (9th ed.) Citation

Rasooli, Rokhsana, et al. "Pirfenidone–Silymarin Combination Mitigates Paraquat-Induced Lung Fibrosis via Oxidative and Pro-Fibrotic Pathway Modulation." Natural Product Communications, vol. 21, no. 2, 2026, p. 1, https://doi.org/10.1177/1934578X251405972.